Dr. Mi earned his Phd from the National University of Singapore, in the department of Chemical and Biomolecular Engineering in 2013. He also holds a BS from Tsinghua University. He joined the laboratory of Andrew Wang in 2015.
Mi’s current research examines the use of nanoparticles to improve cancer immunotherapy.
Cancer immunotherapy is an exciting new strategy in cancer treatment. A successful immunotherapy involves activation of T cells to infiltrate into tumor. Effective T cell activation needs combination of several stimulatory signals. Standard administration of stimulatory agents suffers from suboptimal T cell binding events that only a subset of T cells can bind all the agents together, which lowers the activation efficiency and immune response. Mi will focus my research on simultaneous activation of T cells. He will use the polymeric nanoparticles as a tool for spatial-temporal co-delivery of T cell stimulatory agents to improve immunotherapy.